Swiss Longitudinal Cohort

Hypertension Excellence Centre Lucerne3 sites in 1 country1,000 target enrollmentOctober 2014

ConditionsCardiovascular Risk Factors

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cardiovascular Risk Factors
Sponsor: Hypertension Excellence Centre Lucerne
Enrollment: 1000
Locations: 3
Primary Endpoint: Mortality
Status: Recruiting
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The planned research project is a prospective population-based cohort study, similar to the well-known Framingham study in the United States. So far, there is no similar research project in Switzerland.

It is planned to examine of three Swiss municipalities. Recruitment in a first Swiss municipality (Lostallo/Cama GR) started 2014 and ended in 2019. Overall, 496 participants were recruited in this municipality. The five-year follow-up in this municipality started in 2019. It is planned to start recruitment in a second Swiss municipality (Uznach SG) in 2020.

The examinations embrace a broad spectrum of measurements (for details the investigators refer to the published study protocol).

Registry

clinicaltrials.gov

Start Date

October 2014

End Date

September 2034

Last Updated

6 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Hypertension Excellence Centre Lucerne

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Resident of Cama GR, Lostallo GR, or Uznach SG
•Age ≥6 years (no upper age limit), for voluntary blood sample ≥18 years
•Willing to participate in long-term study
•Written informed consent (in participants ≥6 years and \<18 years signed by parents)